Wei Chen
Afang Zhou
Yunfeng Zhou- 1Department of Thoracic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China
- 2State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, China
A Correction on
Bispecific antibody for lung cancer: mechanisms and clinical insights
By Chen W, Zhou A and Zhou Y (2025). Front. Immunol. 16:1572802. doi: 10.3389/fimmu.2025.1572802
In the published article, there was an error. The first sentence of the Introduction section contained erroneous data for the annual new lung cancer cases. The original text incorrectly stated “22 million new cases,” which should be “2.2 million new cases” as cited in Reference 1.
A correction has been made to the section Introduction, Paragraph 1. This sentence previously stated:
“Lung cancer is one of the world’s most common cancers and the leading cause of cancer-related deaths, with an estimated 22 million new cases and 1.79 million deaths annually (1).”
The corrected sentence appears below:
“Lung cancer is one of the world’s most common cancers and the leading cause of cancer-related deaths, with an estimated 2.2 million new cases and 1.79 million deaths annually (1).”
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: bispecific antibodies, lung cancer, novel therapies, immunotherapy, targeted therapy
Citation: Chen W, Zhou A and Zhou Y (2025) Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights. Front. Immunol. 16:1656082. doi: 10.3389/fimmu.2025.1656082
Received: 29 June 2025; Accepted: 01 July 2025;
Published: 17 July 2025.
Edited and Reviewed by:
Renata Pacholczak-Madej, Maria Skłodowska-Curie National Institute of Oncology, PolandCopyright © 2025 Chen, Zhou and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yunfeng Zhou, eXVuZl96aG91X2h4c3lAMTYzLmNvbQ==